ResearchToxicity and Cosmetic Outcomes of 28 Gy in 5 Fractions Twice per Week Ultrahypofractionated Whole-Breast Irradiation in Early-Stage Breast Cancer
ResearchImpact of Oncotype DX Risk Categorization and Receipt of Chemotherapy on Survival Outcomes Among Patients with Small Node-Negative HR+ Breast Cancer
ResearchTumor-infiltrating microbes and therapy response: a new frontier in triple-negative breast cancer precision oncology
ResearchThe association between local therapies and survival among patients with metastatic inflammatory breast cancer
ResearchOutcomes of once daily and twice daily accelerated partial breast irradiation regimens in hormone receptor positive breast cancer: a single institution experience
ResearchComparing infectious risk of Trastuzumab-deruxtecan to Trastuzumab-emtansine in patients with breast cancer
ResearchImpact of Treatment Package Time on Survival in Patients with Head and Neck Adenoid Cystic Carcinoma
ResearchConcurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial
ResearchQuality of life in early breast cancer patients after adjuvant accelerated partial-breast irradiation (APBI) in randomized trial
ResearchEvaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer
ResearchConvolutional Neural Network for Classification of Oropharynx Cancer with Video Nasopharyngolaryngoscopy